0.52
+0.0106(+2.08%)
Currency In USD
| Previous Close | 0.51 |
| Open | 0.5 |
| Day High | 0.54 |
| Day Low | 0.5 |
| 52-Week High | 6.41 |
| 52-Week Low | 0.46 |
| Volume | 549,799 |
| Average Volume | 22.86M |
| Market Cap | 8.01M |
| PE | 0.69 |
| EPS | 0.75 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.06 |
| Change | 0.01 |
If you invested $1000 in Scienture Holdings, Inc. (SCNX) since IPO date, it would be worth $69.51 as of January 03, 2026 at a share price of $0.521. Whereas If you bought $1000 worth of Scienture Holdings, Inc. (SCNX) shares 1 year ago, it would be worth $69.51 as of January 03, 2026 at a share price of $0.521.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA
GlobeNewswire Inc.
Dec 22, 2025 1:05 PM GMT
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
GlobeNewswire Inc.
Dec 10, 2025 1:05 PM GMT
U.S. Losartan market totals $245M annually with 71M prescriptions COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on prov
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025
GlobeNewswire Inc.
Dec 02, 2025 1:05 PM GMT
COMMACK, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through